Skip to main content

Want a detailed portfolio tracker?

Mereo Biopharma Group (MREO) P/E (2023 - 2026)

Mereo Biopharma Group (MREO) P/E from Mar 31, 2023 to Jul 21, 2026. The TTM Mereo Biopharma Group (MREO) P/E is -1.18. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Mereo Biopharma Group (MREO)

YearP/EChange
2026-1.18-10.92%
2025-1.32-89.09%
2024-12.13-16.81%
2023-14.58N/A

Comparison Mereo Biopharma Group (MREO) P/E with competitors

Mereo Biopharma Group (MREO) P/E is -1.18.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.14%
NBYStablecoin Development Corp0.00-100.36%
ENLVEnlivex Ltd0.07-106.35%
FGENFibroGen Inc0.24-120.36%
CHRSCoherus Biosciences Inc0.85-171.98%
FBIOFortress Biotech Inc0.95-180.50%
ORMPOramed Pharmaceuticals Inc1.50-227.49%
AGENAgenus Inc3.01-355.29%
INVAInnoviva Inc3.15-367.54%
VXRTVaxart Inc3.55-401.10%
CRMDCorMedix Inc3.63-407.78%
CVACCureVac N.V.4.45-477.10%
GLPGGalapagos NV4.86-512.15%
SRPTSarepta Therapeutics Inc4.88-514.12%
ABEOAbeona Therapeutics Inc5.39-556.99%
ABUSArbutus Biopharma Corp5.60-574.64%
ZVRAZevra Therapeutics Inc5.89-599.38%
SPROSpero Therapeutics Inc6.23-628.32%
CGENCompugen Ltd6.31-635.57%
RIGLRigel Pharmaceuticals6.87-682.91%
SLXNSilexion Therapeutics Corp7.30-718.88%
OMEROmeros Corporation9.26-885.36%
AUPHAurinia Pharmaceuticals Inc9.58-913.03%
PLXProtalix BioTherapeutics Inc10.89-1023.81%
ACADAcadia Pharmaceuticals Inc11.73-1094.86%
TBPHTheravance Biopharma Inc12.26-1140.12%
ADMAAdma Biologics Inc12.42-1153.35%
HRMYHarmony Biosciences Holdings Inc13.82-1272.28%
SABSSAB Biotherapeutics Inc14.14-1299.09%
NAGENiagen Bioscience Inc14.82-1356.93%
INCYIncyte Corp15.82-1442.13%
REGNRegeneron Pharmaceuticals Inc15.86-1445.02%
PBYIPuma Biotechnology Inc17.32-1568.78%
CPRXCatalyst Pharmaceuticals Inc17.44-1579.27%
EXELExelixis Inc17.54-1587.64%
TGTXTG Therapeutics Inc18.97-1708.77%
MDXGMimedx Group Inc20.55-1843.34%
XOMAXOMA Royalty Corp22.87-2040.37%
ARGXArgen X SE24.30-2161.10%
CTMXCytomX Therapeutics Inc24.82-2205.48%
XOMAOXOMA Royalty Corp25.34-2249.90%
HALOHalozyme Therapeutics Inc25.62-2273.56%
XOMAPXOMA Royalty Corp25.67-2277.49%
VRTXVertex Pharmaceuticals Inc27.99-2474.68%
RPRXRoyalty Pharma plc - Class A28.69-2533.45%
SLNOSoleno Therapeutics Inc29.02-2561.26%
ASNDAscendis Pharma A/S30.09-2652.04%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3315.93%
APLSApellis Pharmaceuticals Inc39.02-3410.02%
BMRNBiomarin Pharmaceutical Inc42.21-3680.66%
KRYSKrystal Biotech Inc45.34-3946.31%
ONCBeiGene Ltd69.54-5998.84%
PHARPharming Group N.V.75.03-6464.13%
TECHBio-Techne Corp101.96-8748.73%
VCELVericel Corp109.92-9424.20%
ALNYAlnylam Pharmaceuticals Inc117.96-10106.52%
GMABGenmab140.29-12000.32%
TLXTelix Pharmaceuticals Ltd162.15-13854.79%
CORTCorcept Therapeutics Inc212.86-18155.88%